You just read:

FDA Grants Fast Track Designation for aTyr's Resolaris™ to Treat Limb Girdle Muscular Dystrophy 2B and Removes Partial Clinical Hold for Resolaris

News provided by

aTyr Pharma, Inc.

18 Jan, 2017, 08:00 ET